BMAL1 and metabolic disease: Given the role IL-1β plays in perpetuating chronic inflammation in metabolic disorders and that circadian disruption further enhances susceptibility to these disorders (75), our findings may identify BMAL1 as a critical regulator of this glucose metabolism-inflammation feedback loop.